Resveratrol is a compound in red wine, grapes, and peanuts, and it became famous on one claim: that it activates the sirtuin enzymes, mimics calorie restriction, and slows aging. That claim extended life in yeast and improved survival in mice fed a fattening diet. In people it has not held up.
Almost none of a swallowed dose reaches the blood intact, and dietary resveratrol showed no link to living longer across a nine-year study of older adults. What holds up is narrower: better blood sugar in people who have diabetes, lower systolic blood pressure at high doses, and a long record of being well tolerated. For a healthy person there is no established reason to supplement it, and a glass of red wine holds far too little to matter.
Findings & Outcomes
What It Is
Resveratrol is a compound that grapevines and a few other plants make when they are injured or attacked by fungus. It is a plant polyphenol in the stilbene family, and it turns up in grape skins, red wine, peanuts, and some berries, usually in small amounts.
Most people first met it through the French paradox, the observation that some wine-drinking populations had less heart disease than expected from their rich diets, and through supplements sold on the promise of slower aging. A glass of red wine holds only a few milligrams, far below any studied dose, so the resveratrol in wine is not a reason to drink.
Anatomy of the Practice
1In the test tube and the cell
Resveratrol does many things to cells in a dish: it influences the sirtuin enzymes, dampens some inflammatory signals, and acts as an antioxidant. These are the effects the reputation was built on, and they hold up in the test tube. They are also only a starting point, because a compound that acts on a cell at high concentration in glass still has to reach that cell in a living person.
2On the way through the gut and liver
Swallowed resveratrol is absorbed well, but the gut wall and liver attach sulfate and glucuronide groups to it within minutes, so it arrives in the blood almost entirely as conjugates. The levels that act in the dish are far above what an oral dose leaves circulating as the parent molecule. This gap between the dish and the bloodstream explains every human result below.
3Where measured effects do turn up
Despite the low blood levels, human trials do register some changes, mostly in people who started with something to correct: better blood-sugar control in those with diabetes, and lower systolic blood pressure at high doses. The effects are modest, they rest on small trials, and they are specific, far narrower than the broad anti-aging benefit the supplements were sold on.
How It Works
The sirtuins are a family of enzymes that help regulate metabolism and the stress response inside cells. In 2003 a laboratory study reported that resveratrol activates SIRT1, one of these enzymes, and extends the lifespan of yeast; later work in the same line reported longer life in worms, flies, and fish. The appeal was straightforward: calorie restriction reliably extends life in many animals and works partly through sirtuins, and here was a molecule in wine that seemed to produce the same effect without the diet. That is the idea that launched the supplements and the popular science books.
The mechanism turned out to be contested at its root. A 2010 study found that resveratrol did not directly activate SIRT1 in the standard assay once a fluorescent tag was removed from the test peptide, so the original activation looks partly like an artifact of how the enzyme was measured. Researchers still debate how resveratrol touches sirtuins and related pathways, and it plainly changes cell metabolism. The confident claim that resveratrol is a direct sirtuin activator has weakened, and that was the one clean mechanism the anti-aging case had rested on.
Bioavailability is the deeper problem. When six volunteers took a 25 mg oral dose of labeled resveratrol, at least 70% was absorbed, yet the amount of unchanged resveratrol left in the blood was a trace, under 5 ng/mL, because sulfate and glucuronide conjugation happens so fast. The concentrations that act on cells in a dish are difficult to reach in human tissue by swallowing a capsule. Some of the conjugates may be active, and resveratrol may concentrate in the gut lining, so the question stays open. This is the main reason a striking cell or animal finding so often weakens in a person. For two supplements with firmer human evidence, see omega-3 and fish oil and taurine, the other supplement a 2023 study put forward for aging.
What Changed
For a stretch of the 2000s resveratrol was the most talked-about molecule in aging research, and the mouse work drove the attention. In 2006 a study found that resveratrol improved the survival of middle-aged mice fed a high-calorie diet and shifted their physiology toward that of mice on a standard diet, which read as a compound that offsets a bad diet. Press coverage compressed this into a longevity pill, and a company built on sirtuin activators was bought for a large sum, which fixed the story in the public mind.
The correction came from the same field. A 2008 study by many of the same researchers gave resveratrol to mice on a normal diet and found that it mimicked some of the gene-expression patterns of calorie restriction and improved several health markers, yet lifespan did not increase. So the survival benefit was tied to the fattening diet, not to aging in a healthy animal. In people, the trials that followed were mostly small, ran for weeks to months, and disagreed with each other on the main outcomes. And when researchers measured resveratrol intake against actual lifespan, in 783 community-dwelling adults aged 65 and over followed for nine years, they found no association between dietary resveratrol and death, heart disease, cancer, or inflammation. Longevity is the claim resveratrol is named for, and it is the one the human data do not support.
Away from the aging claim, a smaller and steadier picture holds. Pooled human trials point to metabolic effects in the right people: better fasting glucose, insulin, HbA1c, and insulin resistance in people with diabetes, with little happening in people whose glucose was already normal. A separate pooled analysis found high doses lowered systolic blood pressure while leaving the diastolic number unmoved. These are modest, group-specific effects on small evidence bases, and they are the fair way to hold resveratrol today: a compound with a few measured metabolic signals, far from the calorie-restriction substitute it was sold as.
For a healthy person, no human trial has shown resveratrol extends life; the measures that do are exercise, sleep, not smoking, and a whole-food diet.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
How it works
Resveratrol did not directly activate SIRT1 once the fluorescent assay tag was removed
The idea that resveratrol switches on the sirtuin longevity enzymes was the heart of its reputation, but a later lab study could not reproduce that switch without a fluorescent tag on the test, so the direct-activation claim is now in doubt.
The sirtuin story began with Howitz et al. 2003 (Nature), which reported that resveratrol activates SIRT1 and extends replicative lifespan in Saccharomyces cerevisiae. Pacholec et al. 2010 (J Biol Chem) showed that resveratrol and several synthetic candidate activators did not activate SIRT1 against native peptide substrates, and that the apparent activation depended on a non-physiological fluorophore (7-amino-4-methylcoumarin) attached to the assay peptide. Resveratrol still affects cellular metabolism through debated routes, but the specific claim of direct SIRT1 activation is not settled.
The studies · 2
Pacholec et al. 2010, J Biol Chem (not direct activators of SIRT1) · J Biol Chem
Howitz et al. 2003, Nature (original sirtuin-activator report) · Nature
About 70% of an oral dose is absorbed but under 5 ng/mL stays in the blood as resveratrol
Your body absorbs most of the resveratrol you swallow, but the gut and liver convert nearly all of it within minutes, so almost none of the active molecule reaches the blood. The levels that work on cells in a dish are hard to reach by taking a capsule.
Walle et al. 2004 (Drug Metab Dispos) gave six human volunteers 25 mg of 14C-labeled resveratrol orally and intravenously. Absorption was at least 70%, peak plasma resveratrol-plus-metabolites reached about 2 micromolar, but unchanged parent resveratrol was under 5 ng/mL. Rapid sulfate conjugation by intestine and liver was the rate-limiting step. The authors noted that conjugates or accumulation in the aerodigestive epithelium might still have effects, so low plasma parent levels do not by themselves rule out all activity.
The study · 1
Walle et al. 2004, Drug Metab Dispos (high absorption but very low bioavailability) · Drug Metab Dispos
Longevity And Mortality
Dietary resveratrol showed no link to death, heart disease or cancer in 783 older adults over nine years
Among older adults tracked for nine years, how much resveratrol people got from their diet showed no link to how long they lived or to their rates of heart disease, cancer or inflammation.
Semba et al. 2014 (JAMA Intern Med), from the InCHIANTI cohort, measured urinary resveratrol metabolites in 783 adults aged 65 or older. Over nine years, 268 (34.3%) died, with no significant gradient across quartiles of resveratrol metabolites (P = .67) and no association with inflammatory markers, prevalent or incident cardiovascular disease, or cancer. The exposure reflects dietary (food and wine) resveratrol, which is far below supplement doses.
The study · 1
Semba et al. 2014, JAMA Intern Med (resveratrol levels and all-cause mortality, InCHIANTI) · JAMA Intern Med
Resveratrol improved survival in middle-aged mice on a high-calorie diet
Mice fed a fattening diet lived better and longer when given resveratrol, and their bodies looked more like those of mice eating a normal diet. This is an animal result under a specific diet, not something shown in people.
Baur et al. 2006 (Nature) fed middle-aged mice a high-calorie diet with or without resveratrol. Resveratrol increased survival and insulin sensitivity, improved motor function, and produced organ and gene-expression changes overlapping those of caloric restriction. The benefit was demonstrated against the backdrop of a high-calorie diet rather than in normally fed, healthy animals.
The study · 1
Baur et al. 2006, Nature (resveratrol improves survival of mice on a high-calorie diet) · Nature
Resveratrol did not extend lifespan in mice on a standard diet
When mice ate a normal diet rather than a fattening one, resveratrol improved some health markers but did not make them live any longer. The survival benefit seen earlier was tied to the bad diet, not to aging itself.
Pearson et al. 2008 (Cell Metab) reported that resveratrol induced transcriptional patterns in multiple tissues paralleling caloric restriction and every-other-day feeding, and improved several healthspan measures in standard-diet mice, but did not increase lifespan. Many of the same investigators were involved in the 2006 high-calorie-diet survival study, which makes the lifespan null in normally fed mice a direct qualification of that earlier result.
The study · 1
Pearson et al. 2008, Cell Metab (mimics dietary restriction without extending lifespan) · Cell Metab
Blood Sugar
Resveratrol improved blood-sugar control in people with diabetes across 11 trials, with no effect in those without it
In people with diabetes, taking resveratrol modestly improved blood-sugar control and insulin resistance. In people whose blood sugar was already normal, it made no measurable difference.
Liu K et al. 2014 (Am J Clin Nutr) pooled 11 randomized controlled trials totaling 388 subjects. In participants with diabetes, resveratrol significantly lowered fasting glucose, insulin, HbA1c and HOMA-IR. In non-diabetic participants there was no significant effect, and subgroup and meta-regression analyzes in that group were unaffected by BMI, dose, duration or study quality. Trials were small and heterogeneous in dose and duration.
The study · 1
Liu K et al. 2014, Am J Clin Nutr (glucose control and insulin sensitivity meta-analysis) · Am J Clin Nutr
75 mg a day for 12 weeks changed no metabolic measure in nonobese postmenopausal women
In metabolically healthy postmenopausal women, three months of resveratrol raised its blood level but changed nothing measurable about their metabolism.
Yoshino et al. 2012 (Cell Metab) ran a randomized, double-blind, placebo-controlled trial of 75 mg/day resveratrol for 12 weeks in nonobese, postmenopausal women with normal glucose tolerance. Despite a rise in plasma resveratrol, there was no change in insulin sensitivity, body composition, resting metabolic rate, plasma lipids or inflammatory markers. This is the counterpart to the diabetic benefit: where there is no metabolic problem to correct, the trial found no change.
Who this may not transfer to:Tested only in nonobese postmenopausal women; the null result fits the wider pattern that resveratrol moves metabolic measures mainly in people who already have a metabolic problem, so a similar lack of effect in metabolically healthy men is plausible but untested.
The study · 1
Yoshino et al. 2012, Cell Metab (no metabolic improvement in nonobese women) · Cell Metab
Heart And Vascular
At 150 mg a day and up, systolic blood pressure fell about 11.9 mmHg, with no change in the lower number
Resveratrol did not lower blood pressure on average, but at higher doses of 150 mg a day and up it reduced the upper number. The lower number did not move.
Liu Y et al. 2015 (Clin Nutr) pooled six randomized controlled trials totaling 247 subjects. The overall effect on systolic and diastolic pressure was not significant. A pre-specified subgroup taking 150 mg/day or more showed a significant systolic reduction of -11.90 mmHg, though the confidence interval was wide (-20.99 to -2.81), while meta-regression did not confirm a continuous dose effect. Diastolic pressure was unaffected.
The study · 1
Liu Y et al. 2015, Clin Nutr (blood pressure meta-analysis) · Clin Nutr
Ways to Do It
Match what you do to what the evidence supports. For longevity that is little; for metabolic markers in specific groups it is narrow but present. For most people there is no established reason to supplement resveratrol, and no reason to drink wine for it.
Grapes, blueberries, peanuts and dark chocolate carry small amounts of resveratrol as part of whole foods that already belong in a good diet. A glass of red wine holds only a few milligrams, well below any studied dose, so the resveratrol is not a reason to start or increase drinking. This is the baseline: get trace amounts from a varied diet and expect nothing dramatic from them.
If your aim is blood sugar and you have diabetes, plain trans-resveratrol is the studied form, and human trials have run from roughly 150 mg to 1000 mg a day, sometimes higher. Buy the trans form from a supplier carrying an independent testing mark. Make this decision with the clinician who tracks your glucose, adding it to the treatment that manages your diabetes.
The blood-pressure signal showed up only at doses of 150 mg a day and above, and only in the upper number. If this is the goal, it belongs in a conversation with the clinician who follows your readings, weighed against the interaction with blood thinners in the cautions below.
Resveratrol is a commodity, and an unflavored trans-resveratrol from any brand carrying an NSF or Informed Choice mark does the same job as a premium bottle with a longevity claim on the label. The testing mark is what tells you the capsule holds what it says. There is no advanced form shown to solve the bioavailability problem in people.
For the healthy aging the supplement is marketed on, the measures with solid human evidence are exercise, sleep, not smoking and a diet built on whole foods. If the goal is to age well, these come first, and a resveratrol capsule sits after them as a small optional extra.
Go Deeper
- Taurine: the other supplement made famous by a 2023 aging study, and a close parallel in how an animal lifespan result meets thinner human data.
- Omega-3 and fish oil: a supplement whose heart claims were tested in large trials, and an example of how a plausible mechanism fares against hard human outcomes.
The Chinese Medicine View
Resveratrol was first described in the twentieth century and named for the plant it was isolated from, so it has no place in the classical Chinese pharmacopoeia. There is no channel assigned to it, no temperature or flavor given by any historical text, and reading one back into it would be an invention. What the tradition offers instead is a way of thinking about grapes and about wine, the foods this compound travels in, and that framing is laid over the modern isolate as interpretation, held apart from the trial data above.
Grapes are read in Chinese dietary thinking as sweet and sour and roughly neutral, tonifying to Qi and Blood and to the Liver and Kidney; the tradition treats them as a nourishing everyday fruit. Wine is treated altogether differently. It is classed as warm and acrid, something that moves Qi and Blood and can free a stagnant, cold pattern in small amounts, but that readily generates internal heat and damp when taken regularly, burdening the Spleen and clouding the Liver. That caution against habitual drinking runs counter to the popular reading of resveratrol, in which wine is treated as the source of a health-giving molecule. The tradition would not recommend wine for the heart.
The two views touch, without merging, on the person in front of you. A tradition that treats a warming, moving substance as right for one constitution and a burden for someone already running hot or damp would not hand everyone the same daily dose of anything. That instinct sits comfortably beside a modern reading where resveratrol moves blood sugar mainly in people whose sugar was high and blood pressure mainly at high doses, and does little where there was less to change. The framing is offered as a way of thinking, not as a claim that the tradition anticipated the chemistry.
Cautions For This Practice
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Gram-level doses of 2.5 to 5 g a day caused nausea and loose stools in many people
Reviews of resveratrol safety (Shaito et al. 2020, Int J Mol Sci) summarize that low-to-moderate doses are generally well tolerated, while gram-level doses produce dose-related gastrointestinal symptoms. In Brown et al. 2010 (Cancer Res), 40 healthy volunteers took 0.5 to 5 g/day for 29 days; the higher doses produced gastrointestinal complaints and reduced circulating IGF-1 and IGFBP-3, an effect of uncertain clinical meaning.Shaito et al. 2020, Int J Mol Sci (potential adverse effects of resveratrol)Brown et al. 2010, Cancer Res (repeat-dose safety in healthy volunteers)
Resveratrol can add to blood thinners and slow the liver enzymes that clear many drugs
Safety reviews (Shaito et al. 2020, Int J Mol Sci) report that resveratrol inhibits several cytochrome P450 enzymes, including CYP3A4, CYP2C9, CYP2D6 and CYP1A2, that metabolize a large share of prescription drugs, and that it exerts antiplatelet effects. Most of this evidence is in vitro; clinical interaction studies in people are limited, so the practical concern is potential and not well-quantified, and it argues for a clinician or pharmacist reviewing the interaction.Shaito et al. 2020, Int J Mol Sci (adverse effects and drug interactions review)
Blood thinners, antiplatelet drugs and surgery
This is the interaction to raise first. Resveratrol has antiplatelet activity and, at high doses, can inhibit several liver enzymes that clear common drugs, so it may add to the effect of an anticoagulant such as warfarin or an antiplatelet such as aspirin or clopidogrel, and it may raise the levels of medicines processed by those enzymes. If you take a blood thinner, or you have surgery coming up, tell the clinician who manages it before adding resveratrol and about pausing it beforehand.
Drugs cleared by the liver enzymes it affects
In laboratory work resveratrol inhibits cytochrome P450 enzymes including CYP3A4 and CYP2C9, which between them handle a large share of prescription drugs. Most of this evidence comes from the test tube, with few measured interactions in people, but the practical step is simple: if you take regular medication, raise resveratrol with the pharmacist or clinician who knows your full list. A plant compound can still interfere.
High doses can upset the stomach
At the gram-level doses used in some cancer-prevention studies, resveratrol caused mild to moderate stomach symptoms such as nausea, loose stools and abdominal discomfort in a fair number of people. High doses also lowered a growth-factor hormone called IGF-1, an effect of uncertain meaning. There is no established reason to take these large amounts, and the studied metabolic doses are far lower.
Pregnancy, breastfeeding and hormone-sensitive conditions
Supplemental resveratrol has not been well studied in pregnancy or breastfeeding, so food-level intake is the sensible ceiling there. Resveratrol can also have weak estrogen-like activity in some tissues, so anyone with a hormone-sensitive condition should check with their clinician before taking a supplement dose, keeping to food-level amounts otherwise.
Wine is not the way to get it, and anti-aging use is experimental
The wine link is where this compound came from, and it is not a source of a studied dose: the amount in a glass is far below the trial doses, and alcohol carries its own risks. Taking resveratrol in the hope of slowing your own aging is a self-experiment with an effect no human trial has shown, and it should not crowd out the habits with human evidence behind them, such as exercise and sleep.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
Common Questions
Does resveratrol actually help you live longer?
Not in any human data so far. The lifespan results are in yeast, worms, flies and mice, and in mice the clearest survival benefit was in animals fed a high-calorie diet; in normally aging animals it did not appear. When researchers measured resveratrol intake against actual lifespan in 783 older adults over nine years, they found no link with death, heart disease, cancer or inflammation. Whether a supplement dose slows human aging is a question a long randomized trial would have to answer, and that trial has not reported.
Is red wine a good way to get it?
No. A glass of red wine contains only a few milligrams of resveratrol, far below the 150 mg and higher doses used in the trials that measured any effect, so you cannot reach a studied dose by drinking. Alcohol also carries its own well-documented risks. The French paradox made wine and resveratrol famous together, but the amount involved and the risks of drinking mean wine is not the way to pursue any benefit the compound might have.
Does resveratrol help blood sugar or blood pressure?
In specific groups, modestly. A meta-analysis of 11 trials found resveratrol improved fasting glucose, insulin, HbA1c and insulin resistance in people with diabetes, while doing little in people whose glucose was already normal. A separate pooled analysis found that doses of 150 mg a day and above lowered the upper (systolic) blood-pressure number, with no effect on the lower one. Both effects are modest and rest on small trials, and both belong alongside the care of the clinician who tracks those numbers.
Why does something so promising in the lab do so little in people?
Mostly because almost none of a swallowed dose reaches the blood intact. Resveratrol is absorbed well, but the gut and liver convert it to other forms within minutes, so the concentrations that act on cells in a dish are hard to reach in human tissue. The famous mechanism, direct activation of the sirtuin enzymes, was also called into question when a later study could not reproduce it without a fluorescent tag on the test. A strong laboratory result and a low blood level together explain much of the gap.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 12 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 9, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.